Stockreport

Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Nuvectis Pharma, Inc.  (NVCT) 
PDF Fort Lee, NJ , Oct. 07, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused [Read more]